270 related articles for article (PubMed ID: 19563794)
1. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
[TBL] [Abstract][Full Text] [Related]
2. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
3. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.
Bargnoux AS; Bonardet A; Chong G; Garrigue V; Deleuze S; Dupuy AM; Mourad G; Cristol JP
Transplant Proc; 2006 Sep; 38(7):2352-3. PubMed ID: 16980087
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
7. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
Hermida-Cadahia EF; Tutor JC
Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
[TBL] [Abstract][Full Text] [Related]
8. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
De BK; Jimenez E; De S; Sawyer JC; McMillin GA
Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
[TBL] [Abstract][Full Text] [Related]
9. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
[TBL] [Abstract][Full Text] [Related]
11. Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring.
Holt DW; Mandelbrot DA; Tortorici MA; Korth-Bradley JM; Sierka D; Levy DI; See Tai S; Horowitz GL
Clin Transplant; 2014 Feb; 28(2):243-51. PubMed ID: 24476346
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
13. Successful and cost-efficient replacement of immunoassays by tandem mass spectrometry for the quantification of immunosuppressants in the clinical laboratory.
Hétu PO; Robitaille R; Vinet B
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():95-101. PubMed ID: 22100555
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
15. Multi-site, multi-country evaluation of analytical and operational performance of a low-mid volume chemiluminescent immunoassay analyzer.
De Keijzer MH; Perkins S; Motta V; Morelli D; Cristol JP; Dupuy AM; Hong Y; Watanabe S; Waerdt C; Grunewald RW
Clin Lab; 2009; 55(9-10):363-70. PubMed ID: 20099573
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).
Scholer A; Von Rickenbach R; Faffa G; Vetter B
Clin Lab; 2006; 52(7-8):325-34. PubMed ID: 16955630
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)].
Petitjean Lecherbonnier J; Gouarin S; Dina J; Vabret A; Freymuth F
Pathol Biol (Paris); 2007 Dec; 55(10):512-20. PubMed ID: 17959324
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods.
Zochowska D; Bartłomiejczyk I; Kamińska A; Senatorski G; Paczek L
Transplant Proc; 2006; 38(1):78-80. PubMed ID: 16504669
[TBL] [Abstract][Full Text] [Related]
20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
